HOP S. TRAN CAO to Pancreatic Neoplasms
This is a "connection" page, showing publications HOP S. TRAN CAO has written about Pancreatic Neoplasms.
Connection Strength
4.617
-
Nodal downstaging as a treatment goal for node-positive pancreatic cancer. Surgery. 2019 06; 165(6):1144-1150.
Score: 0.391
-
ASO Author Reflections: Role of Preoperative Chemotherapy in the Treatment of Pancreatic Neuroendocrine Liver Metastases. Ann Surg Oncol. 2018 12; 25(Suppl 3):792-793.
Score: 0.383
-
Value of lymph node positivity in treatment planning for early stage pancreatic cancer. Surgery. 2017 09; 162(3):557-567.
Score: 0.350
-
Radiographic tumor-vein interface as a predictor of intraoperative, pathologic, and oncologic outcomes in resectable and borderline resectable pancreatic cancer. J Gastrointest Surg. 2014 Feb; 18(2):269-78; discussion 278.
Score: 0.271
-
Tumor-specific fluorescence antibody imaging enables accurate staging laparoscopy in an orthotopic model of pancreatic cancer. Hepatogastroenterology. 2012 Sep; 59(118):1994-9.
Score: 0.250
-
Submillimeter-resolution fluorescence laparoscopy of pancreatic cancer in a carcinomatosis mouse model visualizes metastases not seen with standard laparoscopy. J Laparoendosc Adv Surg Tech A. 2011 Jul-Aug; 21(6):485-9.
Score: 0.230
-
Metronomic gemcitabine in combination with sunitinib inhibits multisite metastasis and increases survival in an orthotopic model of pancreatic cancer. Mol Cancer Ther. 2010 Jul; 9(7):2068-78.
Score: 0.216
-
Fluorescence laparoscopy imaging of pancreatic tumor progression in an orthotopic mouse model. Surg Endosc. 2011 Jan; 25(1):48-54.
Score: 0.214
-
Cystic neoplasms of the pancreas. Surg Oncol Clin N Am. 2010 Apr; 19(2):267-95.
Score: 0.212
-
Development of the transgenic cyan fluorescent protein (CFP)-expressing nude mouse for "Technicolor" cancer imaging. J Cell Biochem. 2009 May 15; 107(2):328-34.
Score: 0.199
-
The evolving concept of conversion surgery for upfront unresectable upper gastrointestinal and hepato-pancreato-biliary cancers: comprehensive review. BJS Open. 2025 Jul 01; 9(4).
Score: 0.152
-
Robotic Central Pancreatectomy: Patient Selection and Surgical Approach. Ann Surg Oncol. 2025 Jun; 32(6):4128-4129.
Score: 0.149
-
Escalated-dose radiotherapy for unresected locally advanced pancreatic cancer: Patterns of care and survival in the United States. Cancer Med. 2024 Jun; 13(12):e7434.
Score: 0.141
-
Quality of superior mesenteric and hepatic artery dissection in robotic pancreatoduodenectomy for pancreatic cancer. J Hepatobiliary Pancreat Sci. 2023 Jan; 30(1):e1-e2.
Score: 0.125
-
Bayesian Approach to Understand the Association Between Treatment Down-staging and Survival for Patients With Pancreatic Adenocarcinoma. Ann Surg. 2022 03 01; 275(3):415-421.
Score: 0.121
-
Comparative Effectiveness of Neoadjuvant Therapy and Upfront Resection for Patients with Resectable Pancreatic Adenocarcinoma: An Instrumental Variable Analysis. Ann Surg Oncol. 2021 Jun; 28(6):3186-3195.
Score: 0.110
-
External Retraction Technique for Robotic Pancreatoduodenectomy. J Am Coll Surg. 2020 11; 231(5):e8-e10.
Score: 0.109
-
Neoadjuvant Treatment for Patients With Localized Pancreatic Adenocarcinoma: Are We There Yet? JAMA Oncol. 2020 08 01; 6(8):1163-1164.
Score: 0.108
-
Long-Term Assessment of Pancreatic Function After Pancreatectomy for Cystic Neoplasms. J Surg Res. 2020 03; 247:547-555.
Score: 0.103
-
Specific Targeting of Somatostatin Receptor Subtype-2 for Fluorescence-Guided Surgery. Clin Cancer Res. 2019 07 15; 25(14):4332-4342.
Score: 0.099
-
Understaging of clinical stage I pancreatic cancer and the impact of multimodality therapy. Surgery. 2019 02; 165(2):307-314.
Score: 0.095
-
Nutritional and Metabolic Derangements in Pancreatic Cancer and Pancreatic Resection. Nutrients. 2017 Mar 07; 9(3).
Score: 0.086
-
Impact of pancreatectomy on long-term patient-reported symptoms and quality of life in recurrence-free survivors of pancreatic and periampullary neoplasms. J Surg Oncol. 2017 Feb; 115(2):144-150.
Score: 0.084
-
Improved perioperative outcomes with minimally invasive distal pancreatectomy: results from a population-based analysis. JAMA Surg. 2014 Mar; 149(3):237-43.
Score: 0.069
-
Treatment sequencing for resectable pancreatic cancer: influence of early metastases and surgical complications on multimodality therapy completion and survival. J Gastrointest Surg. 2014 Jan; 18(1):16-24; discussion 24-5.
Score: 0.068
-
Therapeutic advances in pancreatic cancer. Gastroenterology. 2013 Jun; 144(6):1316-26.
Score: 0.066
-
Half-antibody functionalized lipid-polymer hybrid nanoparticles for targeted drug delivery to carcinoembryonic antigen presenting pancreatic cancer cells. Mol Pharm. 2010 Jun 07; 7(3):914-20.
Score: 0.054
-
Upregulation of thrombospondin-1 and angiogenesis in an aggressive human pancreatic cancer cell line selected for high metastasis. Mol Cancer Ther. 2009 Jul; 8(7):1779-86.
Score: 0.050
-
Complementarity of ultrasound and fluorescence imaging in an orthotopic mouse model of pancreatic cancer. BMC Cancer. 2009 Apr 08; 9:106.
Score: 0.049
-
Prevalence of and Factors Associated with Financial Toxicity After Pancreatectomy and Gastrectomy. Ann Surg Oncol. 2024 Jul; 31(7):4361-4370.
Score: 0.035
-
Knockdown of the ?(1) integrin subunit reduces primary tumor growth and inhibits pancreatic cancer metastasis. Int J Cancer. 2011 Dec 15; 129(12):2905-15.
Score: 0.014
-
Pseudopodium-enriched atypical kinase 1 regulates the cytoskeleton and cancer progression [corrected]. Proc Natl Acad Sci U S A. 2010 Jun 15; 107(24):10920-5.
Score: 0.013